Conterno is new Lilly U.S. president
Executive Summary
Lilly's U.S. president Deirdre Connelly resigned and will be succeeded by Enrique Conterno, currently senior VP for U.S. health care professional markets, the firm announces Jan. 30. Conterno perhaps beefed up his resume for the job after being appointed more responsibilities last year in overseeing efforts toward health professionals and neuroscience, diabetes and osteoporosis therapeutics when the company restructured to streamline R&D (1"The Pink Sheet," June 2, 2008, p. 25). The leadership shift is effective immediately
You may also be interested in...
Lilly’s former U.S. president joins GSK
Deirdre Connelly joins GlaxoSmithKline as President North American Pharmaceuticals, effective Feb. 9. CEO Andrew Witty said Connelly's track record aligns with the firm's plan to increase payer and physician focus for sales reps in the U.S. Connelly resigned from her position as head of Lilly's U.S. operations Jan. 30 (1"The Pink Sheet," Feb. 2, 2009, In Brief)
Altus Names Gemayel CEO; Milligan Becomes Gilead President
Presidents & CEOs
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.